Diebold Nixdorf DBD
$51.86 +$1.59 (+3.16%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $51.86 0.00%
Open$49.97
Prev close$50.27
Day range$49.92 – $52.07
Volume515.3K
Market cap$1.74B
P/E (TTM)24.6
Dividend yield–
Earnings
Average move on report day±9.1%last 13 reports
Closed higher8 of 1362% of the time
Best reaction+12.4%
Worst reaction-17.2%
Stock move on the day after each report
| Quarter | Report date | Timing | Implied move | Actual move | Versus implied |
|---|---|---|---|---|---|
| 2026/Q3 | 28 Oct 2026 | Pre Market | ±10.8% | -12.91% | Bigger than priced |
| 2026/Q2 | 29 Jul 2026 | Pre Market | ±9.4% | -17.17% | Bigger than priced |
| 2026/Q1 | 30 Apr 2026 | Pre Market | ±10.4% | -7.41% | Within range |
| 2025/Q4 | 12 Feb 2026 | Pre Market | ±9.5% | +4.46% | Within range |
| 2025/Q3 | 5 Nov 2025 | Pre Market | ±9.1% | +12.45% | Bigger than priced |
| 2025/Q2 | 6 Aug 2025 | Pre Market | ±10.1% | +5.78% | Within range |
| 2025/Q1 | 7 May 2025 | Pre Market | ±10.8% | -2.76% | Within range |
| 2024/Q4 | 12 Feb 2025 | Pre Market | ±16.2% | +5.36% | Within range |
| 2024/Q3 | 7 Nov 2024 | Pre Market | ±10.4% | -13.73% | Bigger than priced |
| 2024/Q2 | 7 Aug 2024 | Pre Market | ±21.7% | +10.45% | Within range |
| 2024/Q1 | 2 May 2024 | Pre Market | – | +10.78% | – |
| 2023/Q4 | 14 Feb 2024 | Pre Market | – | +5.07% | – |
| 2023/Q3 | 9 Nov 2023 | Pre Market | – | +9.80% | – |
"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.
Where the revenue comes from
Quarter 2026/Q3
By business line
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$994.30M+5.2% YoY
Operating profit$69.70M-16.7% YoY
Net profit$7.10M-83.0% YoY
Diluted EPS$0.19-82.9% YoY
Free cash flow-$60.30M-346.1% YoY
Operating cash flow-$47.40M
Revenue, last 8 quarters
Net profit, last 8 quarters
Profitability & balance sheet
Gross margin25.0%
Operating margin6.2%
Net margin2.0%
Return on equity7.5%
Return on assets2.1%
Return on invested capital6.7%
Current ratio1.27
Liabilities / assets74.2%
Cash & investments$184.90M
Total debt$949.30M
Net cash (debt)-$764.40M
Free cash flow / sales3.2%
No comments yet — be the first to weigh in on DBD.
Sign in to join the discussion.